Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04525131
Title Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors CicloMed LLC
Indications

urinary bladder cancer

Therapies

CPX-POM

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.